We can’t show the full text here under this license. Use the link below to read it at the source.
Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice
Low to moderate alcohol exposure reduces brain support cell inflammation and memory decline in early-stage Alzheimer's mice
AI simplified
Abstract
Moderate alcohol exposure reduced amyloid beta deposition in the brains of APP/PS1 mice.
- Mice exposed to moderate ethanol showed reduced levels of astrocytic glial fibrillary acidic protein (GFAP) and (ApoE) in the cortex and hippocampus.
- Increased expression of (LRP1) was observed, which may inhibit inflammatory pathways associated with neurodegeneration.
- Levels of pro-inflammatory cytokines IL-1β and TNF-α decreased in male mice following moderate ethanol exposure.
- Female mice exhibited reduced anti-inflammatory cytokines IL-4 and IL-10 without changes in IL-1β and TNF-α levels.
- Aβ plaques were reduced in both sexes, suggesting a potential protective effect of moderate alcohol consumption against Alzheimer's disease.
- Brain activity measured by FDG-PET increased, and cognitive deficits were normalized in both male and female APP/PS1 mice following moderate ethanol exposure.
AI simplified
Key numbers
notable reduction
Reduction in Aβ Plaques
Aβ plaque levels in cortex and hippocampus of ethanol-exposed presymptomatic APP/PS1 mice
170 mg/dl
Blood Alcohol Concentration
Average BAC in presymptomatic APP/PS1 mice after ethanol exposure